Landmark Alzheimer’s prevention trial to evaluate third drug
December 19, 2016
![](https://dian.wustl.edu/wp-content/uploads/2017/01/DIANTUBateman-700x467.jpg)
An international study to test drugs that may prevent or delay Alzheimer’s disease is adding a third drug arm. Participants who receive the drug or placebo will be monitored for at least four years for signs of the disease.
Categories: カテゴリーなし